Home
Browse
Search
Statistics
About
Usage
PMID: 21188243
Ishikawa T, Nakagawa H, Hagiya Y, Nonoguchi N, Miyatake S, Kuroiwa T
Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis.
Adv Pharmacol Sci. 2010;2010:587306. Epub 2010 Jul 8.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
158
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:158:142
status:
VERIFIED
view ABCG2 p.Gln141Lys details
The most extensively studied among those SNPs with potential clinical relevance is 421 C > A resulting in a glutamine to lysine substitution (
Q141K
) in the ABCG2 protein.
Login to comment
159
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:159:4
status:
VERIFIED
view ABCG2 p.Gln141Lys details
The
Q141K
SNP has been identified with varying frequencies in different ethnic groups and was found to be the most relevant in Japanese and Chinese populations (approximately 30% in the allele frequency).
Login to comment
161
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:161:0
status:
VERIFIED
view ABCG2 p.Gln141Lys details
Q141K
has been associated with lower levels of protein expression and impaired transport in vitro [79-84].
Login to comment
163
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:163:17
status:
VERIFIED
view ABCG2 p.Gln141Lys details
Furthermore, the
Q141K
SNP was reportedly associated with a higher incidence of diarrhea in nonsmall cell lung cancer patients treated with gefitinib [88].
Login to comment
164
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:164:67
status:
VERIFIED
view ABCG2 p.Gln141Lys details
It has been demonstrated that the reduced expression levels of the
Q141K
variant may be due to its ubiquitin-mediated proteasomal degradation [89].
Login to comment
167
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 21188243:167:219
status:
NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 21188243:167:212
status:
NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:167:146
status:
VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 21188243:167:124
status:
NEW
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 21188243:167:167
status:
NEW
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 21188243:167:240
status:
NEW
view ABCG2 p.Asn590Tyr details
ABCG2 p.Gln166Glu
X
ABCG2 p.Gln166Glu 21188243:167:160
status:
NEW
view ABCG2 p.Gln166Glu details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 21188243:167:174
status:
NEW
view ABCG2 p.Phe208Ser details
ABCG2 p.Asp620Asn
X
ABCG2 p.Asp620Asn 21188243:167:251
status:
NEW
view ABCG2 p.Asp620Asn details
ABCG2 p.Thr153Met
X
ABCG2 p.Thr153Met 21188243:167:153
status:
NEW
view ABCG2 p.Thr153Met details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 21188243:167:205
status:
NEW
view ABCG2 p.Ser441Asn details
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 21188243:167:226
status:
NEW
view ABCG2 p.Phe489Leu details
ABCG2 p.Phe431Leu
X
ABCG2 p.Phe431Leu 21188243:167:198
status:
NEW
view ABCG2 p.Phe431Leu details
ABCG2 p.Gly51Cys
X
ABCG2 p.Gly51Cys 21188243:167:130
status:
NEW
view ABCG2 p.Gly51Cys details
ABCG2 p.Ser248Pro
X
ABCG2 p.Ser248Pro 21188243:167:181
status:
NEW
view ABCG2 p.Ser248Pro details
ABCG2 p.Phe571Ile
X
ABCG2 p.Phe571Ile 21188243:167:233
status:
NEW
view ABCG2 p.Phe571Ile details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21188243:167:136
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Glu334*
X
ABCG2 p.Glu334* 21188243:167:188
status:
NEW
view ABCG2 p.Glu334* details
Based on the currently available data on SNPs and acquired mutations, we have created a total of 18 variant forms of ABCG2 (
V12M
,
G51C
,
Q126stop
,
Q141K
,
T153M
,
Q166E
,
I206L
,
F208S
,
S248P
,
E334stop
,
F431L
,
S441N
,
R482G
,
R482T
,
F489L
,
F571I
,
N590Y
, and
D620N
) by site-directed mutagenesis and expressed them in insect cells [41, 90].
Login to comment
168
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 21188243:168:23
status:
NEW
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 21188243:168:51
status:
NEW
view ABCG2 p.Ser441Asn details
ABCG2 p.Ser248Pro
X
ABCG2 p.Ser248Pro 21188243:168:30
status:
NEW
view ABCG2 p.Ser248Pro details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21188243:168:13
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Glu334*
X
ABCG2 p.Glu334* 21188243:168:37
status:
NEW
view ABCG2 p.Glu334* details
The variants
Q126stop
,
F208S
,
S248P
,
E334stop
, and
S441N
are defective in the transport of hematoporphyrin (Figure 4(b)).
Login to comment
169
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 21188243:169:4
status:
NEW
view ABCG2 p.Phe489Leu details
The
F489L
variant showed impaired transport activity (Figure 4(b)).
Login to comment
170
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 21188243:170:32
status:
NEW
view ABCG2 p.Phe208Ser details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 21188243:170:46
status:
NEW
view ABCG2 p.Ser441Asn details
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 21188243:170:57
status:
NEW
view ABCG2 p.Phe489Leu details
ABCG2 p.Ser248Pro
X
ABCG2 p.Ser248Pro 21188243:170:39
status:
NEW
view ABCG2 p.Ser248Pro details
Flp-In-293 cells expressing the
F208S
,
S248P
,
S441N
, and
F489L
variants were sensitive to light when cells were treated with pheophorbide a.
Login to comment
177
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 21188243:177:184
status:
NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 21188243:177:402
status:
NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 21188243:177:178
status:
NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 21188243:177:396
status:
NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:177:109
status:
VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 21188243:177:315
status:
VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 21188243:177:90
status:
NEW
view ABCG2 p.Val12Met details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 21188243:177:296
status:
NEW
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 21188243:177:133
status:
NEW
view ABCG2 p.Ile206Leu details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 21188243:177:333
status:
NEW
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 21188243:177:205
status:
NEW
view ABCG2 p.Asn590Tyr details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 21188243:177:384
status:
NEW
view ABCG2 p.Asn590Tyr details
ABCG2 p.Gln166Glu
X
ABCG2 p.Gln166Glu 21188243:177:127
status:
NEW
view ABCG2 p.Gln166Glu details
ABCG2 p.Gln166Glu
X
ABCG2 p.Gln166Glu 21188243:177:327
status:
NEW
view ABCG2 p.Gln166Glu details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 21188243:177:139
status:
NEW
view ABCG2 p.Phe208Ser details
ABCG2 p.Phe208Ser
X
ABCG2 p.Phe208Ser 21188243:177:339
status:
NEW
view ABCG2 p.Phe208Ser details
ABCG2 p.Asp620Asn
X
ABCG2 p.Asp620Asn 21188243:177:211
status:
NEW
view ABCG2 p.Asp620Asn details
ABCG2 p.Asp620Asn
X
ABCG2 p.Asp620Asn 21188243:177:390
status:
NEW
view ABCG2 p.Asp620Asn details
ABCG2 p.Thr153Met
X
ABCG2 p.Thr153Met 21188243:177:115
status:
NEW
view ABCG2 p.Thr153Met details
ABCG2 p.Thr153Met
X
ABCG2 p.Thr153Met 21188243:177:321
status:
NEW
view ABCG2 p.Thr153Met details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 21188243:177:172
status:
NEW
view ABCG2 p.Ser441Asn details
ABCG2 p.Ser441Asn
X
ABCG2 p.Ser441Asn 21188243:177:366
status:
NEW
view ABCG2 p.Ser441Asn details
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 21188243:177:166
status:
NEW
view ABCG2 p.Phe489Leu details
ABCG2 p.Phe489Leu
X
ABCG2 p.Phe489Leu 21188243:177:372
status:
NEW
view ABCG2 p.Phe489Leu details
ABCG2 p.Pro269Ser
X
ABCG2 p.Pro269Ser 21188243:177:235
status:
NEW
view ABCG2 p.Pro269Ser details
ABCG2 p.Phe431Leu
X
ABCG2 p.Phe431Leu 21188243:177:160
status:
NEW
view ABCG2 p.Phe431Leu details
ABCG2 p.Phe431Leu
X
ABCG2 p.Phe431Leu 21188243:177:360
status:
NEW
view ABCG2 p.Phe431Leu details
ABCG2 p.Arg160Gln
X
ABCG2 p.Arg160Gln 21188243:177:121
status:
NEW
view ABCG2 p.Arg160Gln details
ABCG2 p.Gly51Cys
X
ABCG2 p.Gly51Cys 21188243:177:95
status:
NEW
view ABCG2 p.Gly51Cys details
ABCG2 p.Gly51Cys
X
ABCG2 p.Gly51Cys 21188243:177:301
status:
NEW
view ABCG2 p.Gly51Cys details
ABCG2 p.Ser248Pro
X
ABCG2 p.Ser248Pro 21188243:177:145
status:
NEW
view ABCG2 p.Ser248Pro details
ABCG2 p.Ser248Pro
X
ABCG2 p.Ser248Pro 21188243:177:345
status:
NEW
view ABCG2 p.Ser248Pro details
ABCG2 p.Phe571Ile
X
ABCG2 p.Phe571Ile 21188243:177:190
status:
NEW
view ABCG2 p.Phe571Ile details
ABCG2 p.Phe571Ile
X
ABCG2 p.Phe571Ile 21188243:177:378
status:
NEW
view ABCG2 p.Phe571Ile details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21188243:177:100
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 21188243:177:306
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Asp296His
X
ABCG2 p.Asp296His 21188243:177:229
status:
NEW
view ABCG2 p.Asp296His details
ABCG2 p.Ala528Thr
X
ABCG2 p.Ala528Thr 21188243:177:223
status:
NEW
view ABCG2 p.Ala528Thr details
ABCG2 p.Thr542Ala
X
ABCG2 p.Thr542Ala 21188243:177:217
status:
NEW
view ABCG2 p.Thr542Ala details
ABCG2 p.Arg575*
X
ABCG2 p.Arg575* 21188243:177:196
status:
NEW
view ABCG2 p.Arg575* details
ABCG2 p.Glu334*
X
ABCG2 p.Glu334* 21188243:177:151
status:
NEW
view ABCG2 p.Glu334* details
ABCG2 p.Glu334*
X
ABCG2 p.Glu334* 21188243:177:351
status:
NEW
view ABCG2 p.Glu334* details
Gefitinib and imatinib are new anticancer drugs Outside Plasma membrane Inside H2N COOH
V12M
G51C
Q126stop
Q141K
T153M
R160Q
Q166E
I206L
F208S
S248P
E334stop
F431L
F489L
S441N
R482G
R482T
F571I
R575stop
N590Y
D620N
T542A
A528T
D296H
P269S
ATP-binding cassette (a) 0 0.1 0.3 0.4 0.2 0.5 Mock WT
V12M
G51C
Q126stop
Q141K
T153M
Q166E
I206L
F208S
S248P
E334stop
F431L
S441N
F489L
F571I
N590Y
D620N
R482G
R482T
ATP-dependenthematoporphyrin transport(nmol/min/mgprotein) (b) Figure 4: (a) Schematic illustration of human ABCG2 and its nonsynonymous polymorphisms.
Login to comment
179
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 21188243:179:23
status:
NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 21188243:179:13
status:
NEW
view ABCG2 p.Arg482Gly details
The variants
R482G
and
R482T
are acquired mutations.
Login to comment